spironolactone 5 MG/ML Oral Suspension

Verify with CMS →

spironolactone

RxCUI: 104232

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0.6%
Plan Coverage
29
Plans Covering
T1.8
Avg Tier
0%
Prior Auth Required

What the CMS Formulary Data Shows for spironolactone 5 MG/ML Oral Suspension

Per the CMS 2026 Part D formulary file, spironolactone 5 MG/ML Oral Suspension (RxNorm concept RXCUI 104232, generic name spironolactone) appears on 11 distinct formulary files spanning 29 Medicare Part D plan offerings - 0.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.8.

Real-world access to spironolactone 5 MG/ML Oral Suspension depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 54.5% require step therapy. 54.5% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,081,937 Part D beneficiaries filled spironolactone 5 MG/ML Oral Suspension in 2023, with total plan-and-beneficiary spending of $101,773,696 and an average per-beneficiary annual cost of $48.88. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry spironolactone 5 MG/ML Oral Suspension today.

Coverage Details

Formularies covering
11
Plans covering
29
Coverage rate
0.6%
Tier range
Tier 1 – Tier 4
Average tier
Tier 2, Generic

Restrictions

Prior authorization required
0% of formularies
Step therapy required
54.5% of formularies
Quantity limits
54.5% of formularies

2023 Medicare Spending

Beneficiaries
2,081,937
Total spending
$101,773,696
Avg per beneficiary
$48.88

Tier Distribution Across Plans

8 plans
Tier 1, Preferred Generic
11 plans
Tier 2, Generic
4 plans
Tier 3, Preferred Brand
6 plans
Tier 4, Non-Preferred

Medicare Advantage Plans (MA-PD) Covering spironolactone 5 MG/ML Oral Suspension

29 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
PHP (HMO C-SNP) AIDS HEALTHCARE FOUNDATION T1 No $0 CA
VNS Health Total (HMO D-SNP) VNS CHOICE T1 No $0 NY
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T1 No $0 CA
Mass General Brigham SCO (HMO D-SNP) MASS GENERAL BRIGHAM HEALTH PLAN, INC T1 No $0 MA
Mass General Brigham One Care (HMO D-SNP) MASS GENERAL BRIGHAM HEALTH PLAN, INC T1 No $0 MA
Gold Dialysis & Kidney Complete (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T1 No $4.80 FL
Gold Dialysis & Kidney Complete (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T1 No $17.00 AZ
VNS Health EasyCare Plus (HMO D-SNP) VNS CHOICE T1 No $51.60 NY
Gold Heart & Diabetes (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Heart & Diabetes Complete (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Health (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T2 No $0 FL
Gold Heart & Diabetes (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
Gold Heart & Diabetes (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
Gold Dialysis & Kidney (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T2 No $0 AZ
VillageCareMAX Medicare Health Advantage Plan (HMO D-SNP) VILLAGE SENIOR SERVICES CORPORATION T2 No $0 NY
VillageCareMAX Medicare Total Advantage Plan (HMO D-SNP) VILLAGE SENIOR SERVICES CORPORATION T2 No $0 NY
Mass General Brigham Advantage (PPO) Mass General Brigham Health Plan, Inc. T3 No $0 MA
Mass General Brigham Advantage Secure (HMO-POS) Mass General Brigham Health Plan, Inc. T3 No $62.00 MA
Mass General Brigham Advantage Premier (PPO) Mass General Brigham Health Plan, Inc. T3 No $79.70 MA
Mass General Brigham Advantage Signature (PPO) Mass General Brigham Health Plan, Inc. T3 No $147.20 MA
SummaCare Medicare Topaz (HMO) SUMMACARE INC. T4 No $0 OH
SummaCare Medicare Quartz (HMO) SUMMACARE INC. T4 No $0 OH
SummaCare Medicare Garnet (HMO) SUMMACARE INC. T4 No $35.00 OH
SummaCare Medicare Ruby (HMO) SUMMACARE INC. T4 No $50.00 OH
SummaCare Medicare Sapphire (HMO-POS) SUMMACARE INC. T4 No $83.00 OH
SummaCare Medicare Emerald (HMO-POS) SUMMACARE INC. T4 No $100.80 OH

Frequently Asked Questions

Is spironolactone 5 MG/ML Oral Suspension covered by Medicare Part D?

Yes, spironolactone 5 MG/ML Oral Suspension is covered by 29 Medicare Part D plans (0.6% of all Part D formularies).

What tier is spironolactone 5 MG/ML Oral Suspension on Medicare Part D plans?

spironolactone 5 MG/ML Oral Suspension averages Tier 1.8 across Part D plans, ranging from Tier 1 to Tier 4.

Does spironolactone 5 MG/ML Oral Suspension require prior authorization?

0% of Part D formularies require prior authorization for spironolactone 5 MG/ML Oral Suspension. Step therapy: 54.5%. Quantity limits: 54.5%.

How much does Medicare spend on spironolactone 5 MG/ML Oral Suspension?

In 2023, total Medicare Part D spending on spironolactone 5 MG/ML Oral Suspension was $101,773,696, covering 2,081,937 beneficiaries. The average spend per beneficiary was $48.88.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial